#USA #Digital Innovation #Palm Beach Gardens #National Dentex Labs #Paul Kahn

National Dentex Labs Appoints Paul Kahn as Interim CEO

On March 16, 2026, National Dentex Labs (NDX), North America's largest network of dental laboratories, announced the immediate appointment of Paul Kahn as their Interim Chief Executive Officer. Kahn previously held the position of Chief Operating, Transformation, and Financial Officer, succeeding Kevin Mosher in leading the company.

Since joining NDX in May 2025, Kahn has played a pivotal role in harmonizing the financial and operational strategies of the company. His leadership has facilitated the digital transformation efforts of NDX, positioning the organization at the leading edge of prosthetic dentistry through innovative workflows and advanced clinical technologies.

In his new role, Kahn aims to enhance NDX's standing as a leader in the dental industry by merging traditional craftsmanship with state-of-the-art dental technology. "There is tremendous opportunity at NDX," Kahn remarked, expressing admiration for the team's commitment to exceptional customer experiences. He emphasized that while enhancing their digital capabilities, NDX would continue to prioritize a customer-driven approach. This commitment supports the unique needs of every clinician served by the company.

Kahn's vision includes maintaining NDX's momentum and advancing its technological capabilities in modern dentistry, ensuring the highest quality for partners and their patients. "This is an exciting chapter, and I am committed to driving the progress and excellence that NDX is known for," he affirmed.

With an extensive background in organizational transformation, Kahn brings a wealth of experience to his role as CEO, having previously served in leadership positions at multiple Fortune 500 companies and high-growth enterprises, including The Key, Triller, Warner Chappell Music, and Viacom. He is an alumnus of Columbia Business School, where he earned his MBA, and graduated from Binghamton University School of Management.

In addition to his executive duties, Kahn actively contributes to several Boards of Directors, offering strategic insight into corporate evolution and financial stability.

Overview of National Dentex Labs

National Dentex Labs is recognized as a premier provider of dental prosthetics and restorative solutions. Utilizing cutting-edge techniques and technologies, NDX creates a wide array of dental products including dentures, crowns, bridges, implants, surgical guides, appliances, and orthodontics. The company also specializes in headache and sleep therapy products. Since its inception in 2015, NDX has expanded its presence across the nation, responding to the demands of a rapidly evolving marketplace and ensuring the delivery of top-tier restorative solutions to dentists, specialists, and Dental Service Organizations (DSOs) in North America.

With a robust network comprising more than 30 full-service laboratories in the U.S., NDX is dedicated to maintaining high-quality products while offering personalized service. Nearly 1,500 skilled dental professionals are employed by NDX, who diligently serve tens of thousands of dentists and specialists. This commitment solidifies NDX's reputation as the dental lab of choice among dental practices.

To learn more about NDX, please visit National Dentex Labs.